Imis Dogan

Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data

Kathrin Reetz, Imis Dogan, Ana Sofia Costa et al. · The Lancet Neurology · 2015 · 204 citations

Neurobiology Of Disease, Neuroepidemiology, Ataxia Consortium +8

Progression characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study

Kathrin Reetz, Imis Dogan, R.-D Hilgers et al. · The Lancet Neurology · 2016 · 150 citations

Neurodegenerative Diseases, Neurobiology Of Disease, Progression Characteristics +11

Altered resting‐state connectivity in Huntington's Disease

Cornelius J. Werner, Imis Dogan, Christian Saß et al. · Human Brain Mapping · 2013 · 101 citations · Full text

Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study

Kathrin Reetz, Imis Dogan, R.-D Hilgers et al. · The Lancet Neurology · 2021 · 89 citations

Neurobiology Of Disease, Progression Characteristics, European Friedreich +10

Increased brain tissue sodium concentration in Huntington's Disease — A sodium imaging study at 4T

Kathrin Reetz, Sandro Romanzetti, Imis Dogan et al. · NeuroImage · 2012 · 76 citations

Neurodegenerative Diseases, Sodium Homeostasis, Neurophysiology +7